Silvia Stacchiotti, M.D.
S.C. Oncologia Medica 2, Tumori Mesenchimali e Rari, Fondazione IRCCS, Istituto Nazionale dei Tumori
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Silvia Stacchiotti, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:37 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07801222 · A Study to Assess Safety and Efficacy of SOT106 in Patients With LRRC15-positive Advanced Unresectable or Metastatic Osteosarcoma or Soft Tissue SarcomaSOTIO Biotech a.s. · not yet recruiting · Osteosarcoma Metastatic, Soft Tissue Sarcoma (STS), Osteosarcoma, Advanced · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in osteosarcoma.